Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The company is developing GLP-1 drugs still in clinical trials, and its stock has experienced sharp volatility without meaningful net gains over the past year
Glucagon-like peptide-1 receptor in the brain: role in neuroendocrine control of energy metabolism and treatment target for obesity
Shut glucagon off and you do lower glucose, but you also shut off the body's principal counter-regulatory fat-burning signal
Cell Cycle 11(19):35593567
History has shown that several FDA-approved weight-loss medications, such as Fen-Phen and Belviq, were later removed from the market due to serious health concerns
US$ 20.88
US$ 24.79
US$ 22.47
US$ 27.84
US$ 24.33
US$ 22.96
US$ 21.67
US$ 26.17
US$ 22.70
